Carst & Walker represents Gattefossé, a global leader in lipid-based excipients, in their pursuit to reshape the future of animal health. With a history of scientific excellence and a dedication to responsible innovation, Gattefossé is making significant strides in veterinary pharmaceutical formulation by combining safety, efficacy and sustainability to address the evolving challenges faced by veterinarians, formulators and pharmaceutical manufacturers worldwide.
A one health approach to animal welfare
Gattefossé’s approach to veterinary medicine is driven by an understanding of the “One Health” concept, which is a holistic view that considers the interdependence of animal, human and environmental health. Recognising that animal well-being impacts not only farmers and pet owners, but also ecosystems and food chains, Gattefossé is committed to developing solutions that are both effective and ecologically responsible.
This commitment has earned the company recognition with a Gold Medal rating from EcoVadis for its Corporate Social Responsibility (CSR) strategy. Their ongoing efforts to reduce carbon emissions, optimise raw material use and collaborate closely with both academia and the animal health industry have made Gattefossé a trusted name in veterinary excipients globally.
Tailored solutions across the lifecycle of veterinary drugs
As a long-established supplier of excipients for both human and veterinary medicine, Gattefossé partners with formulators and drug developers from early-stage R&D through to market launch. With technical centres of excellence located in China, France, India and the USA, Gattefossé is positioned to provide localised support and regulatory insight to clients in more than 90 countries.
From theoretical training to hands-on workshops, scientific publications and collaborative development, Gattefossé’s knowledge supports innovation across the veterinary healthcare landscape. Their excipients meet the most stringent quality and safety standards and are suitable for a wide range of species, dosage forms and administration routes.
Innovative excipients can be used in soft chews
Gattefossé’s portfolio includes a diverse range of lipid-based excipients such as oils, solvents, co-surfactants, surfactants and emulsifiers. These are used to enhance bioavailability, stabilise active ingredients, modify release profiles and improve palatability or ease of administration.
Functional benefits include:
- Dispersing agents
- Emulsifiers
- Lubricants
- Solubilisers
- Taste-masking agents
- Sustained-release agents
- Skin penetration enhancers
In oral dosage forms, these excipients are ideal for use in suspensions, tablets, pastes and soft chews. For injectable solutions, safe solvents and solubilisers are utilised to ensure reliable drug delivery. Gattefossé’s ingredients have proven efficacy across a wide range of species, from companion animals to livestock and poultry, making them suitable for both therapeutic and preventive medicines.
Practical applications across animal healthcare
Veterinary drug delivery formats supported by Gattefossé include:
- Spot-on solutions
- Pour-on treatments
- Intramammary suspensions
- Oral suspensions and tablets
- Injectable formulations
- Drinking water medications.
By improving solubility and bioavailability, these excipients contribute to better therapeutic outcomes and simplified dosing, improving compliance and overall animal welfare.
According to Cécile Morin, Veterinary Programme Manager at Gattefossé, “We provide strong support to our customers and partners worldwide in developing veterinary medicines that meet the real needs of veterinarians, farmers and pet owners. By improving bioavailability with lipid-based functional excipients, we enhance the efficacy of veterinary medicines while facilitating administration through user-friendly dosage forms”.
Supporting innovation in a growing pet market
As veterinary health becomes increasingly prioritised in both pet care and livestock production, the need for innovative, flexible and sustainable formulation solutions has never been greater. Gattefossé’s technical and regulatory expertise, combined with its emphasis on quality and customer service, helps manufacturers respond to global market needs.
This aligns perfectly with Carst & Walker’s mission: to deliver only the best-in-class ingredients to our clients, backed by technical support and reliable supply chains. Our partnership with Gattefossé enables us to serve the veterinary pharmaceutical sector in East & South Africa, ensuring our customers stay at the forefront of innovation.
If you’re developing veterinary pharmaceuticals and want to improve solubility, enhance bioavailability, or explore new delivery forms, Carst & Walker and Gattefossé are here to help.
Contact our technical team today to discuss how we can support your next veterinary formulation project.
Or, download the brochure for more detailed insights into Gattefossé’s veterinary excipient range.
These ingredients are available in East Africa and South Africa.